Navigation Links
New Advanced Search and Matching Function Drives's Enhanced Functionality

Trial and Free Student Memberships Now Available on Online Community to Facilitate Collaboration to Develop and Commercialize New Medical Device Technologies

FERNANDINA BEACH, Fla., May 8 /PRNewswire/ -- With a growing number of early adopters in just a few short weeks since launch, has added an advanced search function that matches medical device industry participants involved in the discovery, development and commercialization of new medical device technologies. And, to address today's economic challenges, has introduced a trial membership program for a limited time and also has allowed students to sign up for free 12-month memberships.

With its expanded functionality now complete, quickly and efficiently facilitates specific connections among innovators, investors and venture capital firms, academic researchers and technology transfer departments as well as all types of service providers. Without releasing proprietary or confidential information, members now can:

  • Discover and be matched with synergistic individual or organizational partners or identify investment opportunities through a unique search functionality indexed by almost 5,000 proprietary Device Network Attributes (DNA) that e-Zassi(TM) created.
  • Collaborate and communicate with other members of the community with email tools that rival other leading email systems.
  • Calculate and share powerful and mission-critical information using e-Zassi's proprietary Innovation Assessment tool, which currently calculates information on technologies within cardiology, urology, orthopedics and minimally invasive surgery.

Trial and Free Student Memberships also unveiled a new membership structure that includes trial memberships and free memberships for students. Full individual memberships typically cost $1,750, including full access with three InnoVision Reports over 12 months, and the data contained in each InnoVision Report has a documented value of well over $25,000.

"With a drop of 51 percent in venture capital in the first quarter of 2009, the reduced fee for membership will help students, innovators and others impacted by today's economy take advantage of this elite membership community and help bring key people, organizations and technologies together faster to make capital and time go a lot further to bring deals and partnerships to fruition," says Peter M. von Dyck, e-Zassi Chief Executive Officer.

Some of the critical details hindering a technology from being successfully funded, licensed, developed or commercialized include: having a clear regulatory classification and direction; associated clinical endpoints to support the safety and marketing claims to earn market clearances; early stage clarity on the reimbursement and market landscape; and identification of material manufacturing, distribution and sales burdens. These are just some of the many critical elements that the e-Zassi system calculates without any confidential information.

About is a subscription-based online community that provides rapid due diligence, triaging and assessment of new medical device innovations and uniquely categorizes and organizes the information among thousands of proprietary Device Network Attributes (DNA). was spun off Zassi Medical Evolutions(R), a privately held company with more than a decade of innovation and development in medical devices. For more information, visit or call +1.866.474.6328.

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
3. Advanced Age No Bar to Liver Transplant
4. Oncologists are critical in managing psychiatric disorders in patients with advanced cancer
5. Advanced technologies aim to transform the coaching of top athletes
6. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
7. Advanced Life Sciences Joins NASDAQ Capital Market
8. Experimental drug shows promise in advanced kidney cancer
9. TCS Healthcare Technologies Announces Full Integration of Case Management Adherence Guidelines into Acuity Advanced Care(TM) System
10. OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research
11. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
Breaking Medicine Technology: